Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Phase II data on AB-023 support use in prevention of device-associated thrombosis

Dec. 18, 2020

Blood cells. Lots of them

Dec. 17, 2020

Updated results from phase I/II study of FLT-180a in hemophilia B

Dec. 16, 2020

Graphite Bio allowed to initiate phase I/II CEDAR study of GPH-101 in sickle cell disease

Dec. 16, 2020

Akari releases long-term data on nomacopan in paroxysmal nocturnal hemoglobinuria

Dec. 14, 2020

Suzhou Ribo Life Science patents FXI-targeting siRNA

Dec. 14, 2020

Week 48 data reported from phase III PEGASUS trial of pegcetacoplan in PNH

Dec. 10, 2020

Editas submits IND for EDIT-301 for sickle cell disease

Dec. 10, 2020

FDA approves oral once-daily Orladeyo to prevent HAE attacks

Dec. 4, 2020

Biotest presents compositions comprising recombinant factor VIII protein

Dec. 3, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...